• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康后果贴现的理论依据:我们将何去何从?

Theoretical arguments for the discounting of health consequences: where do we go from here?

作者信息

Lazaro Angelina

机构信息

Facultad de Derecho, University of Zaragoza, Zaragoza, Spain.

出版信息

Pharmacoeconomics. 2002;20(14):943-61. doi: 10.2165/00019053-200220140-00001.

DOI:10.2165/00019053-200220140-00001
PMID:12403636
Abstract

Despite the theoretical arguments presented in the literature regarding discounting over the last 25 years, no satisfactory reply has yet been offered to the question of whether health consequences have to be discounted at the same rate as monetary consequences in the economic evaluation of health programmes or interventions designed to improve health. Against this background, the main objective of this paper was to review and systemise these theoretical arguments, with the aim of determining whether any of the positions identified can be accepted without reservation. Having determined that this is not possible, we investigated the rationality of discounting in the literature and, on this basis, propose a potential way to resolve the problem. Thus, we argue that the relationship between the discount of monetary and health consequences has to be determined in an indirect manner, by reference to the relationship maintained by the individual time preference rates for health and money in the context of private and social choice. Although this proposal moves the debate into the empirical field, its advantages must be weighed against the difficulties associated with the estimation of the time preferences.

摘要

尽管在过去25年的文献中提出了关于贴现的理论观点,但对于在健康项目或旨在改善健康的干预措施的经济评估中,健康后果是否必须以与货币后果相同的比率进行贴现这一问题,尚未给出令人满意的答复。在此背景下,本文的主要目的是回顾并系统化这些理论观点,以确定所确定的任何立场是否可以毫无保留地被接受。在确定这是不可能的之后,我们研究了文献中贴现的合理性,并在此基础上提出了一种解决该问题的潜在方法。因此,我们认为,货币和健康后果贴现之间的关系必须通过参考个人在私人和社会选择背景下对健康和金钱的时间偏好率所维持的关系,以间接方式来确定。尽管这一提议将辩论带入了实证领域,但其优点必须与时间偏好估计相关的困难进行权衡。

相似文献

1
Theoretical arguments for the discounting of health consequences: where do we go from here?健康后果贴现的理论依据:我们将何去何从?
Pharmacoeconomics. 2002;20(14):943-61. doi: 10.2165/00019053-200220140-00001.
2
Discounting in the economic evaluation of health care interventions.医疗保健干预措施经济评估中的贴现
Med Care. 1993 May;31(5):403-18. doi: 10.1097/00005650-199305000-00003.
3
Discounting in health care decision-making: time for a change?医疗保健决策中的贴现:是时候做出改变了吗?
J Public Health Med. 1992 Sep;14(3):250-6.
4
Discounting health effects in pharmacoeconomic evaluations: current controversies.药物经济学评价中对健康影响的贴现:当前争议
Pharmacoeconomics. 2005;23(7):639-49. doi: 10.2165/00019053-200523070-00001.
5
Social time preferences for health and money elicited with a choice experiment.通过选择实验引出的健康和金钱的社会时间偏好。
Value Health. 2010 Jun-Jul;13(4):368-74. doi: 10.1111/j.1524-4733.2009.00681.x. Epub 2010 Jan 8.
6
Double discounting of QALYs.质量调整生命年的双重贴现
Health Econ. 2003 Feb;12(2):165-9. doi: 10.1002/hec.718.
7
Reviewing and piloting methods for decreasing discount rates; someone, somewhere in time.回顾和试用降低贴现率的方法;在某个时间、某个地方的某个人。
Expert Rev Pharmacoecon Outcomes Res. 2013 Aug;13(4):523-47. doi: 10.1586/14737167.2013.815404.
8
Discounting, preferences, and paternalism in cost-effectiveness analysis.成本效益分析中的折扣、偏好和家长主义。
Health Care Anal. 2012 Sep;20(3):297-318. doi: 10.1007/s10728-011-0188-6.
9
The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes.经济评估中的分配问题:收入与医疗保健项目成本及后果的估值
Health Econ. 2002 Jan;11(1):55-70. doi: 10.1002/hec.642.
10
Discounting for health effects in cost-benefit and cost-effectiveness analysis.成本效益分析和成本效果分析中健康效应的贴现
Health Econ. 2001 Oct;10(7):587-99. doi: 10.1002/hec.618.

引用本文的文献

1
Discounting money and health effects from communicable and noncommunicable diseases in Thailand.贴现泰国传染病和非传染病的货币和健康影响。
Sci Rep. 2023 Feb 27;13(1):3324. doi: 10.1038/s41598-023-30559-2.
2
Determinants of Lifestyle Choices Among South Korean College Students: An Experimental Analysis.韩国大学生生活方式选择的决定因素:一项实验分析
Risk Manag Healthc Policy. 2022 Jan 20;15:93-105. doi: 10.2147/RMHP.S333968. eCollection 2022.
3
Loss Aversion and Health Behaviors: Results from Two Incentivized Economic Experiments.

本文引用的文献

1
Discounting for health effects in cost-benefit and cost-effectiveness analysis.成本效益分析和成本效果分析中健康效应的贴现
Health Econ. 2001 Oct;10(7):587-99. doi: 10.1002/hec.618.
2
The practice of discounting in economic evaluations of healthcare interventions.医疗保健干预措施经济评估中的贴现做法。
Int J Technol Assess Health Care. 2001 Spring;17(2):236-43. doi: 10.1017/s0266462300105094.
3
Private and social time preferences for health and money: an empirical estimation.健康与金钱的个人和社会时间偏好:一项实证估计。
损失厌恶与健康行为:两项激励性经济实验的结果
Healthcare (Basel). 2021 Aug 13;9(8):1040. doi: 10.3390/healthcare9081040.
4
Differential discounting in the economic evaluation of healthcare programs.医疗保健项目经济评估中的差异贴现
Cost Eff Resour Alloc. 2019 Dec 17;17:29. doi: 10.1186/s12962-019-0196-1. eCollection 2019.
5
Preferences, personality and health behaviors: results from an explorative economic experiment.偏好、个性与健康行为:一项探索性经济实验的结果
Int J Health Econ Manag. 2018 Dec;18(4):437-456. doi: 10.1007/s10754-018-9236-1. Epub 2018 Feb 23.
6
How effective and cost-effective was the national mass media smoking cessation campaign 'Stoptober'?全国性大众媒体戒烟活动“十月戒烟”的效果和成本效益如何?
Drug Alcohol Depend. 2014 Feb 1;135:52-8. doi: 10.1016/j.drugalcdep.2013.11.003. Epub 2013 Nov 20.
7
Research priorities for economic analyses of prevention: current issues and future directions.预防措施经济分析的研究重点:当前问题与未来方向
Prev Sci. 2014 Dec;15(6):789-98. doi: 10.1007/s11121-013-0429-z.
8
Cost-utility estimations of palliative care in patients with pancreatic adenocarcinoma: a retrospective analysis.胰腺癌患者姑息治疗的成本效用评估:一项回顾性分析。
World J Surg. 2013 Aug;37(8):1883-91. doi: 10.1007/s00268-013-2003-z.
9
The economics of primary prevention of cardiovascular disease - a systematic review of economic evaluations.心血管疾病一级预防的经济学——经济评估的系统评价
Cost Eff Resour Alloc. 2007 May 14;5:5. doi: 10.1186/1478-7547-5-5.
10
Adherence of pharmacoeconomic studies to national guidelines in the Netherlands.荷兰药物经济学研究对国家指南的遵循情况。
Pharm World Sci. 2005 Oct;27(5):364-70. doi: 10.1007/s11096-005-7904-y.
Health Econ. 2001 Jun;10(4):351-6. doi: 10.1002/hec.599.
4
Population-based time preferences for future health outcomes.
Med Decis Making. 2000 Jul-Sep;20(3):263-70. doi: 10.1177/0272989X0002000302.
5
Health outcome measures used in cost-effectiveness studies: a review of original articles published between 1986 and 1996.成本效益研究中使用的健康结果测量指标:对1986年至1996年间发表的原创文章的综述
Health Policy. 2000 Mar;51(2):87-99. doi: 10.1016/s0168-8510(00)00058-0.
6
The estimation of marginal time preference in a UK-wide sample (TEMPUS) project.在一个全英国样本(TEMPUS)项目中对边际时间偏好的估计。
Health Technol Assess. 2000;4(1):i-iv, 1-83.
7
Time preferences and preventive health behavior: acceptance of the influenza vaccine.时间偏好与预防性健康行为:流感疫苗的接受情况
Med Decis Making. 1999 Jul-Sep;19(3):307-14. doi: 10.1177/0272989X9901900309.
8
Evaluation of public investment in health care. Is the risk irrelevant?
J Health Econ. 1983 Aug;2(2):161-5. doi: 10.1016/0167-6296(83)90005-x.
9
Valuing health--a "priceless" commodity.
Am Econ Rev. 1987 May;77(2):263-8.
10
Theory and methods of economic evaluation of health care.医疗保健经济评估的理论与方法。
Dev Health Econ Public Policy. 1996;4:1-245.